• Explore /
  • Poster
  • / Sunitinib (SM) in advanced extraskeletal myxoid chondrosarcoma (EMC): Updated analysis in 11 patients (pts).

Sunitinib (SM) in advanced extraskeletal myxoid chondrosarcoma (EMC): Updated analysis in 11 patients (pts).

Abstract Poster

Authors

Salvatore Provenzano

Salvatore Provenzano

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Salvatore Provenzano , Roberta Maestro , Gianpaolo Dagrada , Paola Collini , Maria A. Pantaleo , Annalisa Astolfi , Tiziana Negri , Alessandro Gronchi , Chiara Colombo , Carlo Morosi , Angelo Paolo Dei Tos , Monica Brenca , Maurizio Polano , Silvana Pilotti , Paolo Giovanni Casali , Silvia Stacchiotti

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Citation

J Clin Oncol 34, 2016 (suppl; abstr 11059)

DOI

10.1200/JCO.2016.34.15_suppl.11059

Abstract #

11059

Poster Bd #

185

Abstract Disclosures

Similar Posters

First Author: Silvia Stacchiotti

First Author: Lauren Caitlin Curry

First Author: Jeffrey Graham

First Author: Austin Kalirai